186 related articles for article (PubMed ID: 35991764)
1. A Canadian survey on knowledge of non-alcoholic fatty liver disease among physicians.
Sebastiani G; Ramji A; Swain MG; Patel K
Can Liver J; 2021; 4(2):82-92. PubMed ID: 35991764
[TBL] [Abstract][Full Text] [Related]
2. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?
Wessels DH; Rosenberg Z
World J Hepatol; 2021 Feb; 13(2):233-241. PubMed ID: 33708352
[TBL] [Abstract][Full Text] [Related]
3. A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH survey.
Driessen S; de Jong VD; van Son KC; Klompenhouwer T; Colardelle Y; Alings M; Moreno C; Anker SD; Castro Cabezas M; Holleboom AG; Grobbee DE; Tushuizen ME
United European Gastroenterol J; 2023 Sep; 11(7):654-662. PubMed ID: 37563849
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.
Nadolsky K; Cryer DR; Articolo A; Fisher T; Schneider J; Rinella M
Ann Med; 2023 Dec; 55(1):2211349. PubMed ID: 37171239
[TBL] [Abstract][Full Text] [Related]
5. Understanding Primary Care Physician Perspectives on the Diagnosis and Management of Non-Alcoholic Fatty Liver Disease: A Qualitative Study.
Heredia NI; John JC; Singh S; Hwang JP; Strong LL; Balakrishnan M; McNeill LH
Inquiry; 2024; 61():469580241241272. PubMed ID: 38529894
[TBL] [Abstract][Full Text] [Related]
6. Primary care practitioners survey of non-alcoholic fatty liver disease.
Said A; Gagovic V; Malecki K; Givens ML; Nieto FJ
Ann Hepatol; 2013; 12(5):758-65. PubMed ID: 24018493
[TBL] [Abstract][Full Text] [Related]
7. Awareness, management, and practice patterns of pediatric NAFLD by primary care physicians.
Lee-Kim V; Morkem R; Barber D; Flemming JA; Kehar M
Paediatr Child Health; 2022 May; 27(2):93-98. PubMed ID: 35599680
[TBL] [Abstract][Full Text] [Related]
8. Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions.
Anstee QM; Hallsworth K; Lynch N; Hauvespre A; Mansour E; Kozma S; Marino JP; Bottomley J; Piercy J; Higgins V
JHEP Rep; 2022 Jan; 4(1):100411. PubMed ID: 34977520
[TBL] [Abstract][Full Text] [Related]
9. Differences in NAFLD/NASH Management by Provider Specialty: Opportunities for Optimizing Multidisciplinary Care.
Porayko MK; Articolo A; Cerenzia W; Coleman B; Patel D; Stacy S
J Multidiscip Healthc; 2022; 15():1533-1545. PubMed ID: 35898947
[TBL] [Abstract][Full Text] [Related]
10. Development and implementation of a continuing medical education program on non-alcoholic fatty liver disease for primary care practitioners in Europe.
Papadakis S; Anastasaki M; Gergianaki I; Koek G; Mendive J; Anastasiou F; Heyens L; Garcia-Retortillo M; Muris J; Lionis C
Front Med (Lausanne); 2023; 10():1034626. PubMed ID: 37035308
[TBL] [Abstract][Full Text] [Related]
11. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.
Wieland AC; Quallick M; Truesdale A; Mettler P; Bambha KM
Dig Dis Sci; 2013 Oct; 58(10):2809-16. PubMed ID: 23843097
[TBL] [Abstract][Full Text] [Related]
12. Physicians' practices for diagnosing liver fibrosis in chronic liver diseases: a nationwide, Canadian survey.
Sebastiani G; Ghali P; Wong P; Klein MB; Deschenes M; Myers RP
Can J Gastroenterol Hepatol; 2014 Jan; 28(1):23-30. PubMed ID: 24416739
[TBL] [Abstract][Full Text] [Related]
13. Primary Care Providers and Nonalcoholic Fatty Liver Disease: A Needs Assessment Survey.
Islam KB; Brandman D; Chu JN; Goldman ML; Fox RK
Dig Dis Sci; 2023 Feb; 68(2):434-438. PubMed ID: 36178567
[TBL] [Abstract][Full Text] [Related]
14. Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis.
Cook N; Geier A; Schmid A; Hirschfield G; Kautz A; Schattenberg JM; Balp MM
JHEP Rep; 2020 Apr; 2(2):100081. PubMed ID: 32190823
[TBL] [Abstract][Full Text] [Related]
15. Practice patterns in NAFLD and NASH: real life differs from published guidelines.
Rinella ME; Lominadze Z; Loomba R; Charlton M; Neuschwander-Tetri BA; Caldwell SH; Kowdley K; Harrison SA
Therap Adv Gastroenterol; 2016 Jan; 9(1):4-12. PubMed ID: 26770262
[TBL] [Abstract][Full Text] [Related]
16. Underappreciation of non-alcoholic fatty liver disease by primary care clinicians: limited awareness of surrogate markers of fibrosis.
Patel PJ; Banh X; Horsfall LU; Hayward KL; Hossain F; Johnson T; Stuart KA; Brown NN; Saad N; Clouston A; Irvine KM; Russell AW; Valery PC; Williams S; Powell EE
Intern Med J; 2018 Feb; 48(2):144-151. PubMed ID: 29083080
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
[TBL] [Abstract][Full Text] [Related]
18. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.
Polanco-Briceno S; Glass D; Stuntz M; Caze A
BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270
[TBL] [Abstract][Full Text] [Related]
19. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.
Athyros VG; Alexandrides TK; Bilianou H; Cholongitas E; Doumas M; Ganotakis ES; Goudevenos J; Elisaf MS; Germanidis G; Giouleme O; Karagiannis A; Karvounis C; Katsiki N; Kotsis V; Kountouras J; Liberopoulos E; Pitsavos C; Polyzos S; Rallidis LS; Richter D; Tsapas AG; Tselepis AD; Tsioufis K; Tziomalos K; Tzotzas T; Vasiliadis TG; Vlachopoulos C; Mikhailidis DP; Mantzoros C
Metabolism; 2017 Jun; 71():17-32. PubMed ID: 28521870
[TBL] [Abstract][Full Text] [Related]
20. Awareness and opinions of non-alcoholic fatty liver disease by hospital specialists.
Bergqvist CJ; Skoien R; Horsfall L; Clouston AD; Jonsson JR; Powell EE
Intern Med J; 2013 Mar; 43(3):247-53. PubMed ID: 22646061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
